1. Home
  2. AAPG vs BHC Comparison

AAPG vs BHC Comparison

Compare AAPG & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AAPG

Ascentage Pharma Group International American Depository Shares

N/A

Current Price

$21.01

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Logo Bausch Health Companies Inc.

BHC

Bausch Health Companies Inc.

HOLD

Current Price

$5.46

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAPG
BHC
Founded
2009
N/A
Country
China
Canada
Employees
767
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
AAPG
BHC
Price
$21.01
$5.46
Analyst Decision
Strong Buy
Hold
Analyst Count
5
3
Target Price
$48.40
$8.00
AVG Volume (30 Days)
5.1K
1.8M
Earning Date
05-20-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
423.08
EPS
N/A
N/A
Revenue
N/A
$8,724,000,000.00
Revenue This Year
$290.34
$4.61
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.56
$4.41
52 Week High
$48.45
$8.69

Technical Indicators

Market Signals
Indicator
AAPG
BHC
Relative Strength Index (RSI) 45.05 48.84
Support Level $20.11 $5.48
Resistance Level $25.23 $5.62
Average True Range (ATR) 0.75 0.20
MACD 0.02 -0.01
Stochastic Oscillator 60.95 36.92

Price Performance

Historical Comparison
AAPG
BHC

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.

About BHC Bausch Health Companies Inc.

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.

Share on Social Networks: